Application progress of 18F-FDG PET/CT in bone and soft tissue sarcomas
10.13929/j.issn.1672-8475.2020.02.013
- Author:
Tingting YU
1
Author Information
1. Department of PET/CT, The Second Affiliated Hospital of Harbin Medical University
- Publication Type:Journal Article
- Keywords:
Fluorodeoxyglucose F 18;
Osteosarcoma;
Positron-emission tomography;
Soft tissue neoplasms;
Tomography, X-ray computed
- From:
Chinese Journal of Interventional Imaging and Therapy
2020;17(2):117-120
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of bone and soft tissue sarcomas is relatively low, but most of them are highly malignant and have poor prognosis. Early diagnosis is the key to improve prognosis. 18F-FDG PET/CT can be used to diagnose and differential diagnose bone and soft tissue sarcoma, tumor classification, determine biopsy site, detect tumor recurrence and metastasis, also to evaluate therapeutic efficacy and prognosis, etc. The application advancements of 18F-FDG PET/CT in bone and soft tissue sarcomas were reviewed in this article.
